GilmanA, GoodmanL, RallT, MuradF, eds. Goodman and Gilman's the pharmacological basis of therapeutics.7th ed.New York: Macmillan, 1985.
2.
KatzA. Basic cellular mechanisms of action of the calcium-channel blockers.Am J Cardiol1985; 55: 2B–9B.
3.
JosephsonM, SinghB. Use of calcium antagonists in ventricular dysfunction.Am J Cardiol1985; 55: 81B–8B.
4.
ColucciW., FiferMA, LorellBH, WynneJ. Calcium channel blockers in congestive heart failure: theoretic considerations and clinical experience.Am J Med1985; 78(2B): 9–16.
5.
LeierC, PatrickTJ, HermillerJ. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.Am Heart J1984; 108: 1461–8.
6.
ElkayamU, WeberL, MckayC, RahimtcolaS. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.Am J Cardiol1985; 56: 560–6.
7.
FerlinzJ, CitronD. Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure.Am J Cardiol1983; 51: 1339–45.
8.
VogtA, KreuzerH. Hemodynamic effects of nisoldipine in chronic congestive heart failure.Arzneimittelforschung1983; 33: 877–9.
9.
KimchiA, EllrodtAG, CharuzeY, ShellW, MurataGH. Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker in patients with recurrent ischemia and severe heart failure.Am Heart J1985; 110: 496–8.
10.
EmanuelssonH, HjalmarsonA, HolmbergS, WaagsteinF. Acute haemodynamic effects of felodipine in congestive heart failure.Eur J Clin Pharmacol1985; 28: 489–93.
11.
TimmisAD, CampbellS, MonaghAN MJ, WalkerL, JewittDE. Acute haemodynamic and metabolic effects of felodipine in congestive heart failure.Br Heart J1984; 51: 445–51.